Health Condition 1: 7- Osteopathic Health Condition 2: 7- Osteopathic Health Condition 3: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Control Intervention1: observational study: PROSPECTIVELY IN THE SIX MONTHS DURATION WILL BE RANDOMLY SELECTED AS GROUP A AND GROUP B UNDERGOING FOR UPPER LIMB SURGERIES
GROUP A PATIENTS WILL RECEIV
Sponsors
SREE BALAJI MEDICAL COLLEGE AND HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: Patients receiving 0.25% Levobupivacaine with 1mcg/kg Dexmedetomidine group L Patients receiving 0.375% Ropivacaine with 1mcg/kg Dexmedetomidine group R ASA Grade I and II All age groups Obese patients Patients posted for elective surgeries
Exclusion criteria
Exclusion criteria: ASA III and IV Known case of hypersensitivity reaction to local anesthetics Bleeding diathesis and Peripheral neuropathy and neuromuscular disease and psychiatric disorders Local infection at the site of puncture Patients with polytrauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is an observational study to find out whether 0.25% levobupivacaine 1mcg/kg Dexmedetomidine or 0.375% ropivacaine with 1mcg/kg Dexmedetomidine has the early onset of sensory and motor blockade prolonged duration of analgesia and better hemodynamic stabilityTimepoint: 0 hours and 1 hour till 10 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| duration of analgesia & to assess better hemodynamic stability.Timepoint: at 30mins 1hour 2hour 3hour | — |
Countries
India
Contacts
Public ContactB KALA
SREE BALAJI MEDICAL COLLEGE AND HOSPITAL CHROMEPET
Outcome results
None listed